About the Event
Lower back pain caused by degenerative disc disease costs more than $100B in the U.S. alone.
Join our panel discussion to learn more about the challenges presented by lower back pain and the new technologies with the potential to change lives.
- Kevin T. Foley, M.D., Chairman, Semmes Murphey Neurologic & Spine Institute
- Matt O’Brien, Managing Director and Senior Research Analyst at Piper Sandler
- Flagg Flanagan, CEO and Chairman, DiscGenics, Inc., a company developing regenerative therapies for patients with degenerative diseases of the spine
DiscGenics has developed a single injection allogenic cell therapy that provides sustained pain relief for patients, thanks to its ability to regenerate disc cells and repair damaged tissue.